Publications

Export 8 results:
Sort by: Author Title Type [ Year (Desc)]
2018
Abd El Aziz, R., mary wadie fawzy, Z. S. Noha Khalil, and S. A. Elaty, "Vascular affection in relation to oxidative DNA damage in metabolic syndrome", Therapeutic advances in endocrinology and metabolism, issue 9(2), 2018.
2015
, Assessment of premature coronary atherosclerosis in patients with systemic lupus erythematosus disease, , 2015.
, Disease characteristics of systemic sclerosis among Egyptian patients, , 2015.
Elbasel, M., N. K. M. Khalil, D. Hassan, and H. Sameer, "EVALUATION OF SERUM FERRITIN IN NON-ALCOHOLIC FATTY LIVER DISEASE", International Journal of Current Research Vol. 7, Issue, 05, pp.16143-16146, May, 2015, 2015.
2014
Heshmat, T. S., H. S. Kareem, N. K. Khalil, and O. G. Shaker, The association between the melatonin receptor 1B gene polymorphism rs10830963 and glucose levels in type 2 diabetes. Egypt J Intern Med 2014;26:145-50, , 2014.
Kareem, H. S., N. K. Khalil, N. M. Badr, and F. El-Shamy, The effect of exercise on insulin resistance in obese women with polycystic ovary syndrome. Egypt J Intern Med 2014;26:110-5, , 2014.
Kareem, H. S., M. Radwan, H. Mourad, N. Khalil, and I. Hamdy, "Relation of vitamin D concentration with macrovascular and microvascular complications of diabetes mellitus in egyptians", International Journal of Academic Research, vol. May (6), pp. 108-117, 2014. Abstract
n/a
Badawi, A. I. Z., N. K. M. Khalil, M. I. Nabih, and M. Saeed, "Two cases of Behçet’s disease with major vessel involvement", The Egyptian Rheumatologist, pp. -, 2014. AbstractWebsite

AbstractAim of the work We attempt here to describe 2 cases of Behçet’s disease (BD) with pulmonary vascular complications. Case presentation Two cases of Behçet’s disease with major vessel involvement are presented. The first case presented with hemoptysis and investigations revealed the presence of pulmonary artery aneurysm (PAA). The patient received pulsed methylprednisolone 1 gm/day for 3 successive days and pulse cyclophosphamide 600 mg monthly for 6 months, and oral maintenance therapy 1 mg/kg prednisolone daily. The patient’s symptoms improved within 2 weeks and a follow up \{CT\} angiography after 1 year revealed normal pulmonary arteries. The second case presented with dilated tortuous veins over the chest wall and was diagnosed to have superior vena cava (SVC) obstruction. The patient was prescribed pulsed methylprednisolone 1 gm/day for 3 successive days and pulse cyclophosphamide 600 mg/month for 6 months and oral prednisolone 1 mg/kg/day maintenance therapy, in addition to, oral warfarin therapy 5 mg/day to maintain his İNR\} at 2.5. The patient was discharged after stabilization of his condition. Conclusion Since a significant proportion of patients develops complications in arterial and venous vessels, vascular lesions should be included in the diagnostic criteria of BD. Challenges remain to identify those patients at risk, to understand the cause and best treatment of thrombosis in these patients, and to develop well tolerated and effective therapies to arrest or reverse the course of vasculitis in BD.

Tourism